a

Stryker Reconstructive Business Sales Drop 1.1% Featured

Written by  Jaimie Oh | October 18, 2012
Social sharing
Stryker has reported $781 million in quarterly sales for its reconstructive business line, down 1.1 percent compared to the same quarter last year.
Although the medical device company saw higher unit volumes, these gains were offset by unfavorable changes in price and foreign currency exchange rates. Stryker saw an overall sales gain of 1 percent totaling $2.1 billion for this quarter.

More Articles on Orthopedic Devices:

Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B

Brian McCollum to Lead Orthofix Spine Global Business Unit

Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.

blog comments powered by Disqus